Solstice Health offers an AI-native platform that ingests clinical data, FDA documents and approved literature to generate grounded marketing assets and score them for likelihood of medical, legal and regulatory (MLR) approval. The company combines proprietary pharmaceutical marketing models with in-house subject-matter experts to create, review and measure digital campaigns, programmatic ads and communications for patients and healthcare providers. Customers launch campaigns 12 times faster than with traditional agencies, moving assets to MLR submission in under 48 hours and to market-ready in roughly 10 days, while producing nearly three times more high-quality content per quarter. Solstice reports reducing average MLR review rounds per asset from 3.2 to 1.2 and serves over a dozen pharmaceutical companies, including several top-20 brands across oncology, immunology and metabolic diseases. The company is headquartered in New York and plans to use its recent funding to expand go-to-market efforts, accelerate product development and grow its team.

Total raised

$25M

Funding rounds

2

Latest round

Series A

Latest activity

May 2026